HDAC9 and familial pancreatic carcinoma: It has been reported that the aggregates of ubiquitin-conjugated protein (aggresome) formation block bortezomib-induced apoptosis in pancreatic cancer cells, and inhibition of the formation of the aggresome by the HDAC inhibitor can strongly potentiate the efficacy of bortezomib35.